DOCSLIB.ORG

Hybrid Alphavirus–Rhabdovirus Propagating Replicon Particles Are Versatile and Potent Vaccine Vectors

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hybrid Alphavirus–Rhabdovirus Propagating Replicon Particles Are Versatile and Potent Vaccine Vectors Hybrid alphavirus–rhabdovirus propagating replicon particles are versatile and potent vaccine vectors Nina F. Rose, Jean Publicover, Anasuya Chattopadhyay, and John K. Rose* Department of Pathology, Yale University School of Medicine, New Haven, CT 06510 Edited by Robert A. Lamb, Northwestern University, Evanston, IL, and approved February 20, 2008 (received for review January 11, 2008) Self-propagating, infectious, virus-like particles are generated in infected cells (12) and could be precursors involved in formation animal cell lines transfected with a Semliki Forest virus RNA of the infectious particles containing VSV G (6). replicon encoding a single viral structural protein, the vesicular Experimental SFV particle-based vaccines are normally de- stomatitis virus (VSV) glycoprotein. We show here that these rived from a complementation/packaging system in which SFV infectious particles, which we call propagating replicons, are po- replicons encoding foreign antigenic proteins are packaged into tent inducers of neutralizing antibody in animals yet are nonpatho- SFV-like particles by SFV structural proteins expressed in trans genic. Mice vaccinated with a single dose of the particles generated (5). Such a complementation system is required for alphavirus high titers of VSV-neutralizing antibody and were protected from vector systems because of the strict size limit for encapsidation a subsequent lethal challenge with VSV. Induction of antibody of viral genomic RNA. Unless the structural genes are deleted, required RNA replication. We also report that additional genes there is no space for inclusion of genes expressing foreign (including an HIV-1 envelope protein gene) expressed from the antigens. Because these complemented particles do not encode propagating replicons induced strong cellular immune responses SFV structural proteins, they replicate for only a single cycle to the corresponding proteins after a single inoculation. Our when inoculated into animals. studies reveal the potential of these particles as simple and safe The hybrid SFV/VSV propagating replicon particles that we vaccine vectors inducing strong humoral and cellular immune described infect and propagate in certain cell lines (6) with VSV responses. G as the only viral structural protein. However, the immunoge- nicity of these particles (designated SFVG particles) had not Semliki Forest virus ͉ vesicular stomatitis virus ͉ HIV-1 been tested in an animal model. Here we have examined the potential of these particles as a vaccine vector in a mouse model. NA replicons from alphaviruses including Semliki Forest virus We found that the particles induced a potent neutralizing R(SFV) have been developed and used for transient expression antibody response to VSV in mice. Mice vaccinated with these of foreign proteins in mammalian cells and also as experimental particles were protected from all weight loss and from a lethal vaccine vectors (1–4). The alphavirus genome is a capped and encephalitis caused by a high dose of wild-type VSV given polyadenylated positive-strand RNA molecule Ϸ12 kb in length. intravenously. The genomic RNA itself is an mRNA that encodes the viral We have also tested the immunogenicity of SFVG particles replicase. A subgenomic mRNA copied from the antigenomic expressing HIV-1 envelope (Env) or VSV nucleocapsid (N) RNA after replication encodes the alphavirus structural proteins. proteins behind a second SFV promoter. These vectors generate RNA transcribed from SFV cDNA can initiate viral RNA strong primary CD8 T cell responses to the foreign proteins as replication following transfection into cells (5). well as memory T cell responses that can be recalled to high Our laboratory previously tested an SFV replicon developed levels after boosting. by Liljestro¨m and Garoff (5) for expression of the vesicular Results stomatitis virus (VSV) glycoprotein (G) (6). The starting SFV Induction of Neutralizing Antibodies to VSV G Protein in Mice Inocu- RNA replicon was derived from a DNA copy of SFV from which lated with SFVG Particles Requires Vector Replication. To determine the genes for the SFV structural proteins were removed. The whether the propagating replicon particles were able to induce VSV G gene was inserted in place of genes encoding the SFV antibody responses to VSV G protein in animals and whether structural proteins. VSV G protein is the single transmembrane replication was required for such induction, we inoculated mice by glycoprotein of the prototype rhabdovirus VSV. VSV G medi- the intramuscular (i.m.) route with 6 ϫ 103 infectious units (i.u.) of ates both virus binding and membrane fusion to allow viral entry SFVG particles that were either untreated or inactivated with UV (7, 8). When this SFVG replicon RNA expressing only the SFV light to prevent RNA replication. After 1 month, serum- IMMUNOLOGY replication proteins and VSV G protein was transfected into neutralizing antibody titers to VSV were determined (Fig. 1 Left). BHK-21 cells, it initially replicated in the small fraction of These results showed 100% neutralization of VSV at serum dilu- transfected cells. Surprisingly, it also produced infectious, low tions of 1:160 for SFVG particles but no detectable neutralizing Ab density, membrane-enveloped particles lacking a nucleocapsid (Ͻ1:20) in animals given the UV-inactivated particles. These results protein that budded from the cells and infected and killed all indicate that the incoming G protein on the particles was not cells in the culture within 2–3 days. These infectious particles present in sufficient amounts to induce VSV-neutralizing antibody could be propagated (passaged) indefinitely in tissue culture, and that G protein must be synthesized in infected cells to generate and their infectivity was inactivated by a VSV-neutralizing such responses. antibody that binds the VSV G protein (6, 9). Although the precise mechanism of generation of the SFVG infectious parti- cles remains unknown, it clearly involves release of vesicles Author contributions: N.F.R., J.P., A.C., and J.K.R. designed research; N.F.R., J.P., and A.C. containing VSV G protein and SFV RNA. The replication of all performed research; N.F.R., J.P., A.C., and J.K.R. analyzed data; and N.F.R., J.P., A.C., and positive-strand RNA viruses including SFV occurs in association J.K.R. wrote the paper. with cellular membranes (10). SFV replication occurs in asso- The authors declare no conflict of interest. ciation with cytopathic vacuoles containing invaginations called This article is a PNAS Direct Submission. spherules, which are probably the sites of SFV RNA synthesis *To whom correspondence should be addressed: E-mail: [email protected]. (11–13). These spherules are also seen on the surface of SFV- © 2008 by The National Academy of Sciences of the USA www.pnas.org͞cgi͞doi͞10.1073͞pnas.0800280105 PNAS ͉ April 15, 2008 ͉ vol. 105 ͉ no. 15 ͉ 5839–5843 Downloaded by guest on September 26, 2021 r 105 10000 t h g ei w 1000 y d 100 o b e 100 g en l al 95 SFVG imm 10 ch e- r Naïve %P 1 3 1 90 VSV neutralizing antibody tite SFVG SFVG(UV) SFVG VSV 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 6 x 103 i.u. 105 i.u. Days post challenge Fig. 2. Vaccination with SFVG particles protects mice against pathogenesis Fig. 1. Replication is required for induction of neutralizing antibody by SFVG caused by wild-type VSV. Twelve BALB/c mice were immunized with 5 ϫ 105 i.u. particles. Mice were inoculated i.m. with 6 ϫ 103 i.u. of SFVG untreated or of SFVG particles by i.m. injection. At 36 days after immunization, these mice treated with 100 mJ of UV light (UV) or with 105 i.u. of SFVG or 105 pfu of VSV were challenged with 5 ϫ 107 pfu of wild-type VSV by the i.v. route. Twelve as indicated. Pooled sera from groups of three mice were assayed for neu- nonimmunized BALB/c mice were challenged as controls. After challenge, tralizing titers to VSV on day 28 after inoculation. UV inactivation of SFVG mice were weighed daily for up to 14 days and observed for signs of patho- particles before inoculation abolished generation of anti-VSV G-neutralizing genesis. Any animal exhibiting paralysis or distress during this period was antibody. The neutralizing antibody titer to VSV in sera from mice inoculated killed. The graph shows the average weights of the mice Ϯ one standard with (105 i.u.) of SFVG was equivalent to that in sera from mice inoculated with deviation. Numbers above the x axis indicate the number of mice in the control 105 pfu of VSV (1:5,120). group that died on the corresponding day. We next determined whether the strength of the antibody SFVG Replicon Particles Are Not Pathogenic in Mice. After i.m. response to VSV G was dose-dependent. We inoculated mice injections of SFVG particles, we had not seen any signs of with 105 i.u. of SFVG particles or with 105 plaque-forming units pathogenesis in mice. To determine whether there was any (pfu) of VSV. VSV serum-neutralizing titers were determined at detectable pathogenesis caused by infection by other potentially 28 days after infection by using pooled serum from each group. more pathogenic routes, we gave the SFVG particles by both the The neutralizing antibody responses to VSV in sera from mice 5 inoculated with the high dose (105 i.u.) of SFVG was 1:5,120, i.v. and the intranasal routes (10 i.u.). We then weighed the mice 32-fold higher than that induced in mice inoculated with the daily for 2 weeks and then observed the mice for 60 days and saw lower dose (6 ϫ 103 i.u.) of SFVG. Remarkably, the neutralizing no signs of pathogenesis caused by the particles.
Load more

Recommended publications
  • Guide for Common Viral Diseases of Animals in Louisiana
    Sampling and Testing Guide for Common Viral Diseases of Animals in Louisiana Please click on the species of interest: Cattle Deer and Small Ruminants The Louisiana Animal Swine Disease Diagnostic Horses Laboratory Dogs A service unit of the LSU School of Veterinary Medicine Adapted from Murphy, F.A., et al, Veterinary Virology, 3rd ed. Cats Academic Press, 1999. Compiled by Rob Poston Multi-species: Rabiesvirus DCN LADDL Guide for Common Viral Diseases v. B2 1 Cattle Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 2 Deer and Small Ruminants Please click on the principle system involvement Generalized viral disease Respiratory viral disease Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 3 Swine Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 4 Horses Please click on the principle system involvement Generalized viral diseases Neurological viral diseases Respiratory viral diseases Enteric viral diseases Abortifacient/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 5 Dogs Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Back to the Beginning DCN LADDL Guide for Common Viral Diseases v.
    [Show full text]
  • Characterization of the Rubella Virus Nonstructural Protease Domain and Its Cleavage Site
    JOURNAL OF VIROLOGY, July 1996, p. 4707–4713 Vol. 70, No. 7 0022-538X/96/$04.0010 Copyright q 1996, American Society for Microbiology Characterization of the Rubella Virus Nonstructural Protease Domain and Its Cleavage Site 1 2 2 1 JUN-PING CHEN, JAMES H. STRAUSS, ELLEN G. STRAUSS, AND TERYL K. FREY * Department of Biology, Georgia State University, Atlanta, Georgia 30303,1 and Division of Biology, California Institute of Technology, Pasadena, California 911252 Received 27 October 1995/Accepted 3 April 1996 The region of the rubella virus nonstructural open reading frame that contains the papain-like cysteine protease domain and its cleavage site was expressed with a Sindbis virus vector. Cys-1151 has previously been shown to be required for the activity of the protease (L. D. Marr, C.-Y. Wang, and T. K. Frey, Virology 198:586–592, 1994). Here we show that His-1272 is also necessary for protease activity, consistent with the active site of the enzyme being composed of a catalytic dyad consisting of Cys-1151 and His-1272. By means of radiochemical amino acid sequencing, the site in the polyprotein cleaved by the nonstructural protease was found to follow Gly-1300 in the sequence Gly-1299–Gly-1300–Gly-1301. Mutagenesis studies demonstrated that change of Gly-1300 to alanine or valine abrogated cleavage. In contrast, Gly-1299 and Gly-1301 could be changed to alanine with retention of cleavage, but a change to valine abrogated cleavage. Coexpression of a construct that contains a cleavage site mutation (to serve as a protease) together with a construct that contains a protease mutation (to serve as a substrate) failed to reveal trans cleavage.
    [Show full text]
  • Validation of the Easyscreen Flavivirus Dengue Alphavirus Detection Kit
    RESEARCH ARTICLE Validation of the easyscreen flavivirus dengue alphavirus detection kit based on 3base amplification technology and its application to the 2016/17 Vanuatu dengue outbreak 1 1 1 2 2 Crystal Garae , Kalkoa Kalo , George Junior Pakoa , Rohan Baker , Phill IsaacsID , 2 Douglas Spencer MillarID * a1111111111 1 Vila Central Hospital, Port Vila, Vanuatu, 2 Genetic Signatures, Sydney, Australia a1111111111 a1111111111 * [email protected] a1111111111 a1111111111 Abstract Background OPEN ACCESS The family flaviviridae and alphaviridae contain a diverse group of pathogens that cause sig- Citation: Garae C, Kalo K, Pakoa GJ, Baker R, nificant morbidity and mortality worldwide. Diagnosis of the virus responsible for disease is Isaacs P, Millar DS (2020) Validation of the easyscreen flavivirus dengue alphavirus detection essential to ensure patients receive appropriate clinical management. Very few real-time kit based on 3base amplification technology and its RT-PCR based assays are able to detect the presence of all members of these families application to the 2016/17 Vanuatu dengue using a single primer and probe set. We have developed a novel chemistry, 3base, which outbreak. PLoS ONE 15(1): e0227550. https://doi. org/10.1371/journal.pone.0227550 simplifies the viral nucleic acids allowing the design of RT-PCR assays capable of pan-fam- ily identification. Editor: Abdallah M. Samy, Faculty of Science, Ain Shams University (ASU), EGYPT Methodology/Principal finding Received: April 11, 2019 Synthetic constructs, viral nucleic acids, intact viral particles and characterised reference Accepted: December 16, 2019 materials were used to determine the specificity and sensitivity of the assays. Synthetic con- Published: January 17, 2020 structs demonstrated the sensitivities of the pan-flavivirus detection component were in the Copyright: © 2020 Garae et al.
    [Show full text]
  • Bornavirus Immunopathogenesis in Rodents: Models for Human Neurological Diseases
    Journal of NeuroVirology (1999) 5, 604 ± 612 ã 1999 Journal of NeuroVirology, Inc. http://www.jneurovirology.com Bornavirus immunopathogenesis in rodents: models for human neurological diseases Thomas Briese1, Mady Hornig1 and W Ian Lipkin*,1 1Laboratory for the Study of Emerging Diseases, Department of Neurology, 3101 Gillespie Neuroscience Research Facility, University of California, Irvine, California, CA 92697-4292, USA Although the question of human BDV infection remains to be resolved, burgeoning interest in this unique pathogen has provided tools for exploring the pharmacology and neurochemistry of neuropsychiatric disorders poten- tially linked to BDV infection. Two animal models have been established based on BDV infection of adult or neonatal Lewis rats. Analyis of these models is already yielding insights into mechanisms by which neurotropic agents and/or immune factors may impact developing or mature CNS circuitry to effect complex disturbances in movement and behavior. Keywords: Borna disease virus; neurotropism; humoral and cellular immune response; Th1 ±Th2 shift; apoptosis; dopamine; cytokines Introduction Borna disease virus (BDV), the prototype of a new disorders and schizophrenia (Amsterdam et al, family, Bornaviridae, within the nonsegmented 1985; Bode et al, 1988, 1992, 1993; Fu et al, 1993; negative-strand RNA viruses, infects the central Kishi et al, 1995; Waltrip II et al, 1995), others have nervous system (CNS) of warmblooded animals to not succeeded in replicating these ®ndings (Iwata et cause behavioral disturbances reminiscent of au- al, 1998; Kubo et al, 1997; Lieb et al, 1997; Richt et tism, schizophrenia, and mood disorders (Lipkin et al, 1997). Here we review two rodent models of al, 1995).
    [Show full text]
  • Alphavirus Vectors for Therapy of Neurological Disorders Kenneth Lundstrom* Pantherapeutics, Rue Des Remparts 4, CH1095 Lutry, Switzerland
    ell Res C ea m rc te h S & f o T h l Journal of Lundstrom, J Stem Cell Res Ther 2012, S4 e a r n a r p u DOI: 10.4172/2157-7633.S4-002 y o J ISSN: 2157-7633 Stem Cell Research & Therapy Review Article Open Access Alphavirus Vectors for Therapy of Neurological Disorders Kenneth Lundstrom* PanTherapeutics, Rue des Remparts 4, CH1095 Lutry, Switzerland Abstract Alphavirus vectors engineered for gene delivery and expression of heterologous proteins have been considered as valuable tools for research on neurological disorders. They possess a highly efficient susceptibility for neuronal cells and can provide extreme levels of heterologous gene expression. However, they generally generate short-term transient expression, which might limit their therapeutic use in many neurological disorders often requiring long-term even life-long presence of therapeutic agents. Recent development in gene silencing applying both RNA interference and microRNA approaches will certainly expand the application range. Moreover, alphaviruses provide interesting models for neurological diseases such as demyelinating and spinal motor diseases. Keywords: Alphaviruses; Gene delivery; Neuronal expression; Gene injections into the caudate nucleus showed strong neuronal expression silencing. throughout the 6 month study. No expression was observed in astrocytes and oligodendroglial cells. SV40-based delivery caused no Introduction evidence of inflammation or tissue damage. Both viral and non-viral vectors have provided interesting novel Despite these encouraging results obtained with both non-viral approaches in research on neurological disorders with a great potential and viral vectors described above alternative gene delivery methods for future therapeutic applications too [1,2].
    [Show full text]
  • Producing Vaccines Against Enveloped Viruses in Plants: Making the Impossible, Difficult
    Review Producing Vaccines against Enveloped Viruses in Plants: Making the Impossible, Difficult Hadrien Peyret , John F. C. Steele † , Jae-Wan Jung, Eva C. Thuenemann , Yulia Meshcheriakova and George P. Lomonossoff * Department of Biochemistry and Metabolism, John Innes Centre, Norwich NR4 7UH, UK; [email protected] (H.P.); [email protected] (J.F.C.S.); [email protected] (J.-W.J.); [email protected] (E.C.T.); [email protected] (Y.M.) * Correspondence: [email protected] † Current address: Piramal Healthcare UK Ltd., Piramal Pharma Solutions, Northumberland NE61 3YA, UK. Abstract: The past 30 years have seen the growth of plant molecular farming as an approach to the production of recombinant proteins for pharmaceutical and biotechnological uses. Much of this effort has focused on producing vaccine candidates against viral diseases, including those caused by enveloped viruses. These represent a particular challenge given the difficulties associated with expressing and purifying membrane-bound proteins and achieving correct assembly. Despite this, there have been notable successes both from a biochemical and a clinical perspective, with a number of clinical trials showing great promise. This review will explore the history and current status of plant-produced vaccine candidates against enveloped viruses to date, with a particular focus on virus-like particles (VLPs), which mimic authentic virus structures but do not contain infectious genetic material. Citation: Peyret, H.; Steele, J.F.C.; Jung, J.-W.; Thuenemann, E.C.; Keywords: alphavirus; Bunyavirales; coronavirus; Flaviviridae; hepatitis B virus; human immunode- Meshcheriakova, Y.; Lomonossoff, ficiency virus; Influenza virus; newcastle disease virus; plant molecular farming; plant-produced G.P.
    [Show full text]
  • Risk Groups: Viruses (C) 1988, American Biological Safety Association
    Rev.: 1.0 Risk Groups: Viruses (c) 1988, American Biological Safety Association BL RG RG RG RG RG LCDC-96 Belgium-97 ID Name Viral group Comments BMBL-93 CDC NIH rDNA-97 EU-96 Australia-95 HP AP (Canada) Annex VIII Flaviviridae/ Flavivirus (Grp 2 Absettarov, TBE 4 4 4 implied 3 3 4 + B Arbovirus) Acute haemorrhagic taxonomy 2, Enterovirus 3 conjunctivitis virus Picornaviridae 2 + different 70 (AHC) Adenovirus 4 Adenoviridae 2 2 (incl animal) 2 2 + (human,all types) 5 Aino X-Arboviruses 6 Akabane X-Arboviruses 7 Alastrim Poxviridae Restricted 4 4, Foot-and- 8 Aphthovirus Picornaviridae 2 mouth disease + viruses 9 Araguari X-Arboviruses (feces of children 10 Astroviridae Astroviridae 2 2 + + and lambs) Avian leukosis virus 11 Viral vector/Animal retrovirus 1 3 (wild strain) + (ALV) 3, (Rous 12 Avian sarcoma virus Viral vector/Animal retrovirus 1 sarcoma virus, + RSV wild strain) 13 Baculovirus Viral vector/Animal virus 1 + Togaviridae/ Alphavirus (Grp 14 Barmah Forest 2 A Arbovirus) 15 Batama X-Arboviruses 16 Batken X-Arboviruses Togaviridae/ Alphavirus (Grp 17 Bebaru virus 2 2 2 2 + A Arbovirus) 18 Bhanja X-Arboviruses 19 Bimbo X-Arboviruses Blood-borne hepatitis 20 viruses not yet Unclassified viruses 2 implied 2 implied 3 (**)D 3 + identified 21 Bluetongue X-Arboviruses 22 Bobaya X-Arboviruses 23 Bobia X-Arboviruses Bovine 24 immunodeficiency Viral vector/Animal retrovirus 3 (wild strain) + virus (BIV) 3, Bovine Bovine leukemia 25 Viral vector/Animal retrovirus 1 lymphosarcoma + virus (BLV) virus wild strain Bovine papilloma Papovavirus/
    [Show full text]
  • The Togavirus RNA Replication Complex
    The Togavirus RNA Replication Complex Pekka Kujala Institute of Biotechnology Department of Biosciences, Division of Biochemistry and Viikki Graduate School in Biosciences University of Helsinki, Finland ACADEMIC DISSERTATION To be presented, with the permission of the Faculty of Science of the University of Helsinki, for public criticism in the auditorium 1041 at Viikki Biocenter (Viikinkaari 5, Helsinki) on June 21st, 2000, at 12 o’clock noon. Helsinki 2000 Supervised by: Professor Leevi Kääriäinen Institute of Biotechnology University of Helsinki Reviewed by: Professor Carl-Henrik von Bonsdorff Department of Virology, Haartman Institute University of Helsinki and Docent Vesa Olkkonen Department of Biochemistry National Public Health Institute Helsinki Opponent: Docent Anu Jalanko Department of Human Molecular Genetics National Public Health Institute Helsinki ISBN 951-45-9443-6 Helsinki 2000 To the memory of my father THE TOGAVIRUS RNA REPLICATION COMPLEX ABBREVIATIONS ORIGINAL PUBLICATIONS ABSTRACT 1 INTRODUCTION 2 1. Togaviruses 2 1.1 Alphaviruses 2 1.1.1. Semliki Forest virus 3 1.1.2. SFV virion structure 4 1.2. Rubiviruses 4 1.2.1. Rubella virus 4 1.2.2. RUB virion structure 5 2. Replication cycle of togaviruses 5 2.1. The alphavirus replication cycle 7 2.1.1. Alphavirus entry 7 2.1.2. Alphavirus replication and translation of the nonstructural polyprotein 7 2.1.3. Translation of alphavirus structural proteins and virus maturation 8 2.1.4. SFV in cell culture 9 2.2. The rubella virus replication cycle 11 2.2.1. RUB entry and translation of the nonstructural polyprotein 11 2.2.2. Translation of RUB structural proteins and virus maturation 11 2.2.3.
    [Show full text]
  • Rapid, Specific Detection of Alphaviruses from Tissue Cultures Using a Replicon-Defective Reporter Gene Assay
    Rapid, Specific Detection of Alphaviruses from Tissue Cultures Using a Replicon-Defective Reporter Gene Assay Jiangjiao Li1., Wuyang Zhu1., Huanqin Wang1, Jiandong Li2, Quanfu Zhang2, Ying He1, Jia Li1, Juanjuan Fu1, Dexin Li2, Guodong Liang1* 1 Department of Viral Encephalitis, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (IVDC, China CDC), Beijing, China, 2 State Key Laboratory for Infectious Disease Prevention and Control (SKLID), Department of Viral Hemorrhagic Fever (IVDC, China CDC), Beijing, China Abstract We established a rapid, specific technique for detecting alphaviruses using a replicon-defective reporter gene assay derived from the Sindbis virus XJ-160. The pVaXJ expression vector containing the XJ-160 genome was engineered to form the expression vectors pVaXJ-EGFP expressing enhanced green fluorescence protein (EGFP) or pVaXJ-GLuc expressing Gaussia luciferase (GLuc). The replicon-defective reporter plasmids pVaXJ-EGFPDnsp4 and pVaXJ-GLucDnsp4 were constructed by deleting 1139 bp in the non-structural protein 4 (nsP4) gene. The deletion in the nsP4 gene prevented the defective replicons from replicating and expressing reporter genes in transfected BHK-21 cells. However, when these transfected cells were infected with an alphavirus, the non-structural proteins expressed by the alphavirus could act on the defective replicons in trans and induce the expression of the reporter genes. The replicon-defective plasmids were used to visualize the presence of alphavirus qualitatively or detect it quantitatively. Specificity tests showed that this assay could detect a variety of alphaviruses from tissue cultures, while other RNA viruses, such as Japanese encephalitis virus and Tahyna virus, gave negative results with this system.
    [Show full text]
  • Medical Aspects of Biological Warfare
    Alphavirus Encephalitides Chapter 20 ALPHAVIRUS ENCEPHALITIDES SHELLEY P. HONNOLD, DVM, PhD*; ERIC C. MOSSEL, PhD†; LESLEY C. DUPUY, PhD‡; ELAINE M. MORAZZANI, PhD§; SHANNON S. MARTIN, PhD¥; MARY KATE HART, PhD¶; GEORGE V. LUDWIG, PhD**; MICHAEL D. PARKER, PhD††; JONATHAN F. SMITH, PhD‡‡; DOUGLAS S. REED, PhD§§; and PAMELA J. GLASS, PhD¥¥ INTRODUCTION HISTORY AND SIGNIFICANCE ANTIGENICITY AND EPIDEMIOLOGY Antigenic and Genetic Relationships Epidemiology and Ecology STRUCTURE AND REPLICATION OF ALPHAVIRUSES Virion Structure PATHOGENESIS CLINICAL DISEASE AND DIAGNOSIS Venezuelan Equine Encephalitis Eastern Equine Encephalitis Western Equine Encephalitis Differential Diagnosis of Alphavirus Encephalitis Medical Management and Prevention IMMUNOPROPHYLAXIS Relevant Immune Effector Mechanisms Passive Immunization Active Immunization THERAPEUTICS SUMMARY 479 244-949 DLA DS.indb 479 6/4/18 11:58 AM Medical Aspects of Biological Warfare *Lieutenant Colonel, Veterinary Corps, US Army; Director, Research Support and Chief, Pathology Division, US Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Maryland 21702; formerly, Biodefense Research Pathologist, Pathology Division, US Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Maryland †Major, Medical Service Corps, US Army Reserve; Microbiologist, Division of Virology, US Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Maryland 21702; formerly, Science and Technology Advisor, Detachment
    [Show full text]
  • Genetic and Epidemiological Characterization of Stretch Lagoon Orbivirus, a Novel Orbivirus Isolated from Culex and Aedes Mosquitoes in Northern Australia
    Journal of General Virology (2009), 90, 1433–1439 DOI 10.1099/vir.0.010074-0 Genetic and epidemiological characterization of Stretch Lagoon orbivirus, a novel orbivirus isolated from Culex and Aedes mosquitoes in northern Australia Chris Cowled,1 Gustavo Palacios,2 Lorna Melville,3 Richard Weir,3 Susan Walsh,3 Steven Davis,3 Aneta Gubala,1 W. Ian Lipkin,2 Thomas Briese2 and David Boyle1 Correspondence 1CSIRO Livestock Industries, Australian Animal Health Laboratory, East Geelong, VIC 3220, Chris Cowled Australia [email protected] 2Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA 3Northern Territory Department of Primary Industries, Fisheries and Mines, Berrimah Veterinary Laboratories, Berrimah, Northern Territory 0801, Australia Stretch Lagoon orbivirus (SLOV) was isolated in 2002 from pooled Culex annulirostris mosquitoes collected at Stretch Lagoon, near the Wolfe Creek national park in the Kimberley region of Western Australia. Conventional serological tests were unable to identify the isolate, and electron microscopy indicated a virus of the genus Orbivirus, family Reoviridae. Here, a cDNA subtraction method was used to obtain approximately one-third of the viral genome, and further sequencing was performed to complete the sequences of segment 1 (viral polymerase) and segment 2 (conserved inner-core protein). Phylogenetic analysis showed that SLOV should be considered a new species within the genus Orbivirus. A real-time RT-PCR test was designed to study the epidemiology of SLOV in the field. Six additional isolates of SLOV were identified, Received 4 January 2009 including isolates from four additional locations and two additional mosquito species. Horses, Accepted 8 March 2009 donkeys and goats were implicated as potential vertebrate hosts in a serological survey.
    [Show full text]
  • Alphavirus-Induced Membrane Rearrangements During Replication, Assembly, and Budding
    pathogens Review Alphavirus-Induced Membrane Rearrangements during Replication, Assembly, and Budding Zeinab Elmasri 1,2, Benjamin L. Nasal 2 and Joyce Jose 1,2,* 1 Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA; [email protected] 2 Department of Biochemistry & Molecular Biology, Eberly College of Science, The Pennsylvania State University, University Park, PA 16802, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-814-863-8806 Abstract: Alphaviruses are arthropod-borne viruses mainly transmitted by hematophagous insects that cause moderate to fatal disease in humans and other animals. Currently, there are no approved vaccines or antivirals to mitigate alphavirus infections. In this review, we summarize the current knowledge of alphavirus-induced structures and their functions in infected cells. Throughout their lifecycle, alphaviruses induce several structural modifications, including replication spherules, type I and type II cytopathic vacuoles, and filopodial extensions. Type I cytopathic vacuoles are replication-induced structures containing replication spherules that are sites of RNA replication on the endosomal and lysosomal limiting membrane. Type II cytopathic vacuoles are assembly induced structures that originate from the Golgi apparatus. Filopodial extensions are induced at the plasma membrane and are involved in budding and cell-to-cell transport of virions. This review provides an overview of the viral and host factors involved in the biogenesis and function of these virus-induced structures. Understanding virus–host interactions in infected cells will lead to the identification of Citation: Elmasri, Z.; Nasal, B.L.; new targets for antiviral discovery. Jose, J. Alphavirus-Induced Membrane Rearrangements during Keywords: Togaviridae; alphavirus; spherule; replication; cytopathic vacuole; nucleocapsid core; Replication, Assembly, and Budding.
    [Show full text]